Structure of Daratumumab
CAS No.: 945721-28-8
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Daratumumab is a humanized IgG1 monoclonal antibody that depletes B cells by binding to the CD38 antigen. Daratumumab has potential for multiple myeloma research.
Synonyms: Anti-Human CD38, Human Antibody
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 945721-28-8 |
M.W : | 145.26 kDa |
SMILES Code : | NONE |
Synonyms : |
Anti-Human CD38, Human Antibody
|
MDL No. : | N/A |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319 |
Precautionary Statements: | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT02116569 | Multiple Myeloma | PHASE1 | COMPLETED | 2025-09-15 | Nagoya, Japan|Tokyo, Japan |
NCT05913596 | Antibody-mediated Rejection|Ki... More >>dney Tranplant Less << | RECRUITING | 2024-08-30 | 79# Qingchun Road, Hangzhou, Z... More >>hejiang, 310003, China Less << | |
NCT02852837 | Multiple Myeloma | PHASE1 | COMPLETED | 2019-12-13 | Beijing, China|Hangzhou, China... More >>|Shanghai, China|Suzhou, China|Tianjin, China Less << |
NCT03475628 | Multiple Myeloma | PHASE2 | UNKNOWN | 2020-02-20 | General Hospital of Athens "Al... More >>exandra", Athens, Attica, 11528, Greece Less << |
NCT04230031 | Multiple Myeloma | PHASE2 | WITHDRAWN | 2025-01-27 | Levine Cancer Institute, Charl... More >>otte, North Carolina, 28204, United States Less << |
NCT03207542 | Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Less << | PHASE2 | WITHDRAWN | 2025-07-21 | - |
NCT05054478 | Plasma Cell Leukemia | PHASE2 | NOT_YET_RECRUITING | 2025-02-28 | - |
NCT05832216 | Aplastic Anemia|Platelet Trans... More >>fusion Refractoriness Less << | PHASE1 | COMPLETED | 2024-12-01 | Regenerative Medicine Center, ... More >>Tianjin, Tianjin, China Less << |
NCT03697629 | Multiple Myeloma in Relapse | PHASE2 | COMPLETED | 2021-12-20 | Kingston Health Sciences Centr... More >>e, Kingston, Ontario, K7L 2V7, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|H?pital Maisonneuve-Rosemont, Montréal, Quebec, H1T 2M4, Canada|McGill University Health Centre, Montréal, Quebec, H4A 3J1, Canada|H?pital de l'Enfant-Jésus, Québec City, Quebec, G1J 1Z4, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, S7N 4H4, Canada Less << |
NCT04088903 | Allosensitization|Heart Transp... More >>lant Failure and Rejection Less << | PHASE1 | WITHDRAWN | 2023-04-01 | - |
NCT04121260 | Multiple Myeloma | PHASE1 | COMPLETED | 2023-10-13 | Peking University Third Hospit... More >>al, Beijing, 100191, China|The Third Xiangya Hospital, Central South University, Changsha, 410013, China|Nanfang Hospital, Guangzhou, 510515, China|Zhongda Hospital,Southeast University, Nanjing, 210009, China|Institute of Hematology & Blood Diseases Hospital, Tianjin, 300320, China Less << |
NCT03768960 | Multiple Myeloma | PHASE4 | COMPLETED | 2022-07-16 | Avron Hospitals Pvt. Ltd, Ahme... More >>dabad, 380013, India|M S Ramaiah Medical College and Hospital, Bengaluru, 560054, India|Sparsh Hospitals & Critical Care (Pvt) Ltd, Bhubaneshwar, 751007, India|Apollo Hospitals, Bhubaneswar, 751005, India|Post Graduate Institute of Medical Education And Research PGIMER, Chandigarh, 160012, India|Apollo Hospitals, Hyderabad, 500033, India|Basavatarakam Indo-American Hospital, Hyderabad, 500034, India|Cytecare Hospitals Pvt. Ltd, Karnataka, 560064, India|Tata Medical Center, Kolkata, 700156, India|Shatabdi Super Speciality Hospital, Mumbai Naka, 422005, India|Kingsway Hospital, Nagpur, 440001, India|Apex Wellness Hospital, Nashik, 422009, India|All India Institute of Medical Sciences, New Delhi, 110029, India|Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605008, India|Deenanath Mangeshkar Hospital and Research Centre, Pune, 411004, India|Noble Hospital Pvt Ltd, Pune, 411013, India Less << |
NCT03095118 | Membranoproliferative Glomerul... More >>onephritis Less << | PHASE2 | COMPLETED | 2020-05-12 | Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less << |
NCT03035357 | Malignant Neoplasms of Male Ge... More >>nital Organs|Prostate Cancer Less << | PHASE2 | WITHDRAWN | 2019-03-01 | - |
NCT02477891 | Multiple Myeloma | APPROVED_FOR_MARKETING | - | Phoenix, Arizona, United State... More >>s|Little Rock, Arkansas, United States|Duarte, California, United States|Fountain Valley, California, United States|Gilroy, California, United States|Greenbrae, California, United States|Los Angeles, California, United States|West Hollywood, California, United States|Denver, Colorado, United States|New Haven, Connecticut, United States|Jacksonville, Florida, United States|Ocala, Florida, United States|West Palm Beach, Florida, United States|Atlanta, Georgia, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Indianapolis, Indiana, United States|Iowa City, Iowa, United States|Topeka, Kansas, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Bethesda, Maryland, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Saint Louis, Missouri, United States|Great Falls, Montana, United States|Omaha, Nebraska, United States|Flemington, New Jersey, United States|Hackensack, New Jersey, United States|New Brunswick, New Jersey, United States|Buffalo, New York, United States|New York, New York, United States|Chapel Hill, North Carolina, United States|Charlotte, North Carolina, United States|Corvallis, Oregon, United States|Hershey, Pennsylvania, United States|Charleston, South Carolina, United States|Greenville, South Carolina, United States|Dallas, Texas, United States|Houston, Texas, United States|Fairfax, Virginia, United States|Barretos, Brazil|Joao Pessoa, Brazil|Porto Alegre, Brazil|Rio De Janeiro, Brazil|Salvador, Brazil|Sao Paulo, Brazil|Kobe-City, Japan|Moscow, Russian Federation|Novosibirsk, Russian Federation|Saint-Petersburg, Russian Federation|Samara, Russian Federation|Volgograd, Russian Federation|Barcelona, Spain|Granada, Spain|Las Palmas De Gran Canaria, Spain|Madrid, Spain|Mallorca, Spain|Pamplona, Spain|Salamanca, Spain|Santander, Spain|Santiago De Compostela, Spain|Toledo, Spain|Valencia, Spain|Valladolid, Spain|Zaragoza, Spain|Blackpool, United Kingdom|Bournemouth, United Kingdom|Dundee, United Kingdom|Glasgow, United Kingdom|Kent, United Kingdom|Leeds, United Kingdom|Londonderry, United Kingdom|London, United Kingdom|Manchester, United Kingdom|Newcastle, United Kingdom|Nottingham, United Kingdom|Stoke On Trent, United Kingdom|Wolverhampton, United Kingdom Less << | |
NCT04868838 | Lupus Nephritis | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-07-26 | Mayo Clinic in Rochester, Roch... More >>ester, Minnesota, 55905, United States Less << |
NCT03236428 | Monoclonal Gammopathy|Smolderi... More >>ng Multiple Myeloma Less << | PHASE2 | ACTIVE_NOT_RECRUITING | 2026-10-04 | Pacific Cancer Care, Monterey,... More >> California, 93940, United States|Colorado Blood Cancer Institute, Denver, Colorado, 80218, United States|Massachusetts General Hospital, Boston, Massachusetts, 02214, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Insitute, Detroit, Michigan, 48201, United States Less << |
NCT03187262 | Waldenstr?m Macroglobulinemia | PHASE2 | COMPLETED | 2021-12-31 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02214, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|University of Washington, Seattle, Washington, 98109, United States Less << |
NCT04972942 | T-cell Acute Lymphoblastic Leu... More >>kemia|T-Cell Acute Lymphoblastic Lymphoma Less << | PHASE1 | RECRUITING | 2025-09-28 | New York Medical College, Valh... More >>alla, New York, 10595, United States Less << |
NCT02413489 | Lymphoma, Mantle-Cell|Lymphoma... More >>, Large B-Cell, Diffuse|Lymphoma, Follicular Less << | PHASE2 | TERMINATED | 2017-06-01 | Duarte, California, United Sta... More >>tes|Fountain Valley, California, United States|Jacksonville, Florida, United States|Pembroke Pines, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Rochester, Minnesota, United States|Omaha, Nebraska, United States|New Brunswick, New Jersey, United States|Pittsburgh, Pennsylvania, United States|Houston, Texas, United States|Seattle, Washington, United States|Adelaide, Australia|Box Hill, Australia|Melbourne, Australia|Brugge, Belgium|Gent, Belgium|Lille, France|Limoges Cedex, France|Nantes Cedex 01, France|Paris Cedex 10, France|Pessac, France|Pierre Benite, France|Rouen Cedex, France|Goyang si, Korea, Republic of|Seoul, Korea, Republic of|Amsterdam, Netherlands|Rotterdam, Netherlands|Utrecht, Netherlands|Ankara, Turkey|Atakum, Turkey|Istanbul, Turkey|Kocaeli, Turkey Less << |
NCT02816476 | Amyloidosis | PHASE2 | COMPLETED | 2025-10-20 | CHU d'Angers, Angers, France|C... More >>HU de Caen, Caen, 14000, France|CHU de Limoges, Limoges, 87042, France|CHU de Lyon Sud, Lyon, France|APHP - Necker, Paris, France|APHP - Saint Antoine, Paris, France|APHP - Saint Louis, Paris, France|CHU Poitiers, Poitiers, France|CHU de Rennes, Rennes, France|Amyloidosis Research and Treatment Center, Pavia, Italy Less << |
NCT04024384 | Multiple Myeloma | PHASE2 | WITHDRAWN | 2025-07-24 | Service d'hématologie clinique... More >> et thérapie cellulaire, Paris, 75012, France Less << |
NCT02927925 | Lymphoma | PHASE2 | COMPLETED | 2020-01-07 | Cancer Hospital, Chinese Acade... More >>my of Medical Sciences, Beijing, 100021, China|Beijing Cancer Hospital, Beijing, 100142, China|Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China|1st Affiliated Hospital of Zhejiang University Medical College, Hangzhou, 310003, China|Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, 200025, China|Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong|National Cancer Center, Goyang-si, 10408, Korea, Republic of|Severance Hospital, Seoul, 03722, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, 06591, Korea, Republic of|Seoul National University Hospital, Seoul, 3080, Korea, Republic of|Asan Medical Center, Seoul, 5505, Korea, Republic of|Singapore General Hospital, Singapore, 169608, Singapore|National Cancer Centre Singapore, Singapore, 169610, Singapore|Changhua Christian Hospital, Changhua, 50006, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan Less << |
NCT03992170 | Myeloma Multiple | PHASE2 | UNKNOWN | 2022-12-31 | Azienda Ospedaliera Universita... More >>ria Senese, Siena, 53100, Italy Less << |
NCT04251065 | Refractory T-Cell Lymphoma|Rel... More >>apsed T-Cell Lymphoma Less << | PHASE2 | UNKNOWN | 2022-11-15 | IRCCS Istituto Tumori Giovanni... More >> Paolo II - U.O.C Ematologia, Bari, 70124, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia, Meldola, Forlì-Cesena, Italy|ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia, Milano, 20162, Italy|A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia, Palermo, 90146, Italy|Ospedale Guglielmo da Saliceto - U.O.Ematologia, Piacenza, 29121, Italy|A.O.U. Citta della Salute e della Scienza di Torino - Ematologia Universitaria, Torino, 10126, Italy|Trieste - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia, Trieste, 34121 Francesco, Italy Less << |
NCT04264884 | - | APPROVED_FOR_MARKETING | - | - | |
NCT05835726 | Multiple Myeloma|Daratumumab|A... More >>utologous Stem Cell Transplantation|Leukapheresis Less << | RECRUITING | 2024-04-30 | Fondazione Policlinico Univers... More >>itario A.Gemelli IRCCS, Rome, 00168, Italy Less << | |
NCT04656951 | Multiple Myeloma | PHASE2 | RECRUITING | 2025-12-29 | University of Cologne, Cologne... More >>, 50937, Germany Less << |
NCT05654506 | Proliferative Glomerulonephrit... More >>is With Monoclonal IgG Deposits Less << | PHASE2 | RECRUITING | 2025-08-26 | Mayo Clinic, Jacksonville, Flo... More >>rida, 32224, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|University North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States Less << |
NCT05088330 | Newly Diagnosed Multiple Myelo... More >>ma Less << | UNKNOWN | 2024-12-31 | - | |
NCT04922723 | Glioblastoma | PHASE1|PHASE2 | RECRUITING | 2025-08-24 | West Virginia University Cance... More >>r Institute Mary Babb Randolph Cancer Center, Morgantown, West Virginia, 26506, United States Less << |
NCT06549634 | Acute Kidney Injury|Multiple M... More >>yeloma|Light Chain Nephropathy Less << | RECRUITING | 2025-10-26 | Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States Less << |
Tags: Daratumumab | Anti-Human CD38, Human Antibody | CD38 | CD38/monoclonal antibody | Immunology/Inflammation | Human Inhibitory Monoclonal Antibody | 945721-28-8
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL